Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | SELP | P16109 | 1/20 | 0.32 |
| ▸ | BCHE | P06276 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL796260 | 0.91 | TSHR (0.46) | L3MBTL1KMT2AMEN1TSHRLMNA | |
| SCHEMBL16186745 | 0.82 | L3MBTL1 (0.37) | L3MBTL1KMT2AMEN1TSHRLMNA | |
| SCHEMBL25502843 | 0.81 | L3MBTL1 (0.55) | L3MBTL1KMT2AMEN1TSHRLMNA | |
| SCHEMBL25502819 | 0.81 | L3MBTL1 (0.55) | L3MBTL1KMT2AMEN1TSHRLMNA | |
| SCHEMBL19398465 | 0.80 | L3MBTL1 (0.36) | L3MBTL1KMT2AMEN1SELP | |
| SCHEMBL15730317 | 0.78 | L3MBTL1 (0.56) | L3MBTL1KMT2AMEN1LMNAALDH1A1 | |
| SCHEMBL16189505 | 0.77 | L3MBTL1 (0.48) | L3MBTL1KMT2AMEN1TSHRLMNA | |
| SCHEMBL7563649 | 0.77 | L3MBTL1 (0.60) | L3MBTL1KMT2AMEN1TSHRLMNA | |
| SCHEMBL25503299 | 0.77 | L3MBTL1 (0.60) | L3MBTL1KMT2AMEN1TSHRLMNA | |
| SCHEMBL25503494 | 0.77 | L3MBTL1 (0.60) | L3MBTL1KMT2AMEN1TSHRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9402925-B2 | Probes and methods of imaging a bacterial infection | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIO (US) | 2016-08-02 | — | — | US | disclosed |
| US-20140314671-A1 | PROBES AND METHODS OF IMAGING A BACTERIAL INFECTION | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2014-10-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140314671-A1 | PROBES AND METHODS OF IMAGING A BACTERIAL INFECTION | MPI, MGAM, TREH | L3MBTL1 882/4885KMT2A 4520/4885MEN1 1869/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.